Back

Risk factors and possible mechanisms of high on treatment platelet reactivity with clopidogrel therapy in Chinese patients with CHD

28 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Acute coronary syndromes Thrombosis and platelets ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Jian Cao

Chinese PLA General Hospital, Beijing (China)

72 More presentations in this session

Presentation thumbnail
Professor S. Perlini (Pavia, IT)
Abstract
Presentation thumbnail
Doctor V. Bongard (Toulouse, FR)
Abstract
Presentation thumbnail
Doctor Y. Yang (Taoyuan, TW)
Abstract Slides
Presentation thumbnail
Doctor V. Kashtalap (Kemerovo, RU)
Abstract Slides
Presentation thumbnail
Mrs G. Veldre (Tartu, EE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 4 - Acute coronary syndromes

The Event

Event poster

ESC Congress 2017

28 August 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Impact of clopidogrel metabolizer status on platelet aggregation and association with outcomes in AF patients undergoing PCI
30 August 2025
thumbnail
Congress Presentation
Prognostic value of diffuse high-risk plaque in patients with acute myocardial infarction: a three-vessel optical coherence tomography study
1 September 2024
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
28 August 2023
thumbnail
Congress Presentation
Is there an inter-manufacturer difference in generic clopidogrel response?
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources